ClinicalTrials.gg
Drug

Candesartan clinical trials

Also written Blopress.

Includes 39 studies of Candesartan cilexetil.

studies test it
104
open now
5
in phase 3
31
first study started
1998

How each study uses candesartan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the candesartan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
4 Jun 1998 · ATACAND · NDA 020838 (FDA, Drugs@FDA; as candesartan cilexetil)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Candesartan
45
Atacand
20
Candesartan 16mg and Amlodipine 5mg
2
Candemore tablet
2

Brand

Blopress
3

In one entry with another drug

Given together, or one or the other

Candesartan + Chlorthalidone
2

Studies by the year they started

100 studies that test it; most in 2006 (11)

Studies that test candesartan, by start year
YearStudies
19982
19993
20001
20015
20021
20032
20042
20058
200611
20074
20085
20097
20102
20113
20124
20137
20149
20154
20164
20171
20182
20194
20202
20211
20222
20231
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
22
Phase 2
21
Phase 3
31
Phase 4
25
No phase
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 50 · Other 54

AstraZeneca (17) · Chong Kun Dang Pharmaceutical (7) · Takeda (4) · HK inno.N Corporation (3) · GlaxoSmithKline (3) · Emory University (2) · Baylor College of Medicine (2) · Mayo Clinic (2)

Often tested with

Tested in the same studies.

Amlodipine (9) · Ramipril (7) · Hydrochlorothiazide (6) · Lisinopril (5) · Valsartan (4) · Enalapril (4) · Chlorthalidone (3) · Rosuvastatin (3)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses candesartan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 104

See all 104 studies that test candesartan →

Given beside what is tested · 10 — candesartan is usual care or a partner of the new treatment
As the comparator · 17 — what is tested is compared with candesartan

Codes

What other systems call candesartan · ClinicalTrials.gg INT003731

  • MeSH (NLM) C081643candesartanConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) S8Q36MD2XXCANDESARTANConfirmed FDA, NLM, Wikidata
  • RxNorm 214354Confirmed FDA, Wikidata
  • Wikidata Q415970candesartanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C65284CandesartanOne source FDA
  • DrugBank DB13919One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.